Literature DB >> 17109993

Gadolinium deposition in nephrogenic fibrosing dermopathy.

Alan S Boyd1, John A Zic, Jerrold L Abraham.   

Abstract

There is growing recognition of the association between the use of gadolinium-containing radiocontrast agents for magnetic resonance imaging and the serious dermal and systemic disease nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis (NFD/NSF). The pathogenesis of this entity remains unclear; however, our recent observations suggest a likely mechanism for the initial dermal manifestations of this gadolinium toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109993     DOI: 10.1016/j.jaad.2006.10.048

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  75 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

2.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

3.  Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

Authors:  Sameh K Morcos; John Haylor
Journal:  World J Radiol       Date:  2010-11-28

Review 4.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 5.  Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?

Authors:  Alexander R Rosenkranz; Thomas Grobner; Gert J Mayer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide.

Authors:  Tim Leiner; Christoph U Herborn; Mathias Goyen
Journal:  Eur Radiol       Date:  2007-04-26       Impact factor: 5.315

7.  [Nephrogenic systemic fibrosis].

Authors:  W Samtleben
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

8.  Application of magnetic resonance urography in diagnosis of congenital urogenital anomalies in children.

Authors:  Seyedmehdi Payabvash; Abdol-Mohammad Kajbafzadeh; Parisa Saeedi; Zhina Sadeghi; Azadeh Elmi; Mehrzad Mehdizadeh
Journal:  Pediatr Surg Int       Date:  2008-07-31       Impact factor: 1.827

9.  Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.

Authors:  Josef A Schroeder; Christian Weingart; Brigitte Coras; Ingrid Hausser; Stephan Reinhold; Matthias Mack; Volker Seybold; Thomas Vogt; Bernhard Banas; Ferdinand Hofstaedter; Bernhard K Krämer
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

Review 10.  Contrast-induced nephropathy: pathogenesis and prevention.

Authors:  Robert E Cronin
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.